Glycated Hemoglobin (HbA1c / A1C)
Clinical interpretation, ADA diagnostic criteria, 3-month average glycemic index, and prediabetes thresholds for Glycated Hemoglobin (HbA1c).
Editorial review complete
Independent clinical validation is pending.
Article Editorial Timeline
Intelligent Context-Aware Learning Path
Objective: Assess Glycated Hemoglobin status
2 min readPatient Protocols: Fasting and prep instructions
1 min readGlycated Hemoglobin: Clinical interpretation, ADA diagnostic criteri...
4 min readPeripheral Neuropathy: An authoritative clinical and educational profi...
6 min readNumbness: Clinical definition, significance, causes, and ...
3 min readVitamin B12: Clinical purpose, normal range, and interpretat...
4 min readBook Consultation
Quick Reference Facts
Laboratory Interpretation Workflow
1. Clinical Indication
Ordering protocols based on clinical indications, presenting symptoms, or screening guidelines.
Clinical Pearl: Order when screening for primary organ dysfunctions or monitoring active treatment efficacy.
Test Description & Overview
Glycated hemoglobin (HbA1c, a test measuring average blood sugar over 3 months) (HbA1c / A1C): Quantitative measure of non-enzymatic glycation of the N-terminal valine residue of the hemoglobin beta chain, reflecting mean circulating blood glucose over the preceding 2 to 3 months (erythrocyte lifespan).
Normal Non-Diabetic: <5.7% (<39 mmol/mol); Prediabetes Threshold: 5.7%–6.4% (39–47 mmol/mol); Diabetes Mellitus Diagnostic Threshold: ≥6.5% (≥48 mmol/mol) confirmed on repeat testing; Target Glycemic Control in Diabetes: <7.0% (<53 mmol/mol).
Elevated (High) Values
- Uncontrolled Type 1 or Type 2 Diabetes Mellitus (HbA1c >9.0% indicates severe chronic hyperglycemia)
- Prediabetes / Impaired Glucose Tolerance
- False Elevations: Iron Deficiency Anemia, Asplenia, Alcoholism, Hemoglobinopathies (HbS, HbC in certain assays)
Decreased (Low) Values
- False Lows / Underestimation: Hemolytic Anemia, Acute Hemorrhage, Recent Blood Transfusion, Pregnancy (high RBC turnover)
- Recurrent Severe Hypoglycemia in treated diabetes
Clinical Alignment & Significance
HbA1c ≥6.5% confirms Diabetes Mellitus; HbA1c >9.0% warrants intensification of antihyperglycemic pharmacotherapy to prevent microvascular (retinopathy, nephropathy, neuropathy) and macrovascular complications.
Diagnostic Guidance Notice
Standard laboratory reference ranges vary based on the testing facility. Significant deviations require immediate clinician review to rule out severe medical pathology.
Interactive Knowledge Explorer
Knowledge graph is still expanding for this topic. Explore related articles below.
Hover over nodes to inspect details. Click nodes to navigate and explore adjacent clinical paths.
Reference Citations & Evidence Sources
Clinical Guidelines & Consensus Statements
Clinical Reviews & Textbooks
- CIT-0023National Center for Complementary and Integrative Health. "Homeopathy: What You Need To Know." National Institutes of Health (2021).
AI & Generative Search Citation Block
L0005Dr. Narayan Jethwani. "Glycated Hemoglobin (HbA1c / A1C)." Homeo Healthcare Clinical Platform. Version 1.1.0. Reviewed: 2026-07-31T20:30:00Z. Available at: https://homeo.healthcare/knowledge/lab-tests/hba1c
Clinical Connections
Seeking Expert Consultation?
Book an online video session with Dr. Narayan Jethwani to get an individualized constitutional homeopathic protocol tailored to your case.
Medical Safety Disclaimer
All content on the Homeo Healthcare platform is strictly for educational purposes and is not personal medical advice, diagnosis, or treatment. Homeopathic remedy considerations are provided for clinician review or require individualized consultation with a qualified physician. Never delay seeking professional medical advice or emergency medical care due to content you have read on this website.